Kazia Therapeutics Limite...

NASDAQ: KZIA · Real-Time Price · USD
7.90
-0.37 (-4.47%)
At close: Aug 15, 2025, 3:59 PM
8.04
1.71%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kazia Therapeutics Income Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
Revenue
2.48M 560.00 555.00 -2.9M -2.89M 15.19M 15.18M 363.6K
Cost of Revenue
n/a n/a n/a n/a n/a 2.88M 2.88M 9.85M
Gross Profit
2.48M 560.00 555.00 -2.9M -2.89M 12.31M 12.3M -9.49M
Operating Income
-28.46M -19.39M -24.15M -25.58M -25.38M -13.39M -6.38M -12.95M
Interest Income
6.45K 28.87K 22.56K 244.00 2.09K 13.4K 42.24K 64.17K
Pretax Income
-27.05M -15.97M -20.74M -25.59M -25.38M -15.91M -8.91M -13.25M
Net Income
-26.78M -15.7M -20.47M -25.4M -25.01M -15.26M -8.42M -12.95M
Selling & General & Admin
13.56M 8.86M 8.58M 7.03M 5.24M 5.93M 7.02M 5.16M
Research & Development
17.38M 10.53M 15.56M 18.54M 20.17M 22.67M 14.54M 8.16M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
30.94M 15.92M 20.76M 25.59M 25.39M 31.12M 24.13M 13.68M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a 127.04K 127.04K n/a n/a n/a
Cost & Expenses
30.94M 15.92M 20.76M 25.59M 25.39M 31.12M 24.13M 13.68M
Income Tax Expense
271K 271.09K 271.09K 187.65K 368.08K 651.22K 484.35K 298.19K
Shares Outstanding (Basic)
575.2K 479.6K 456K 291.4K 266K 264K 264K 214.8K
Shares Outstanding (Diluted)
575.2K 479.6K 456K 291.4K 266K 264K 264K 214.8K
EPS (Basic)
-49.6 -33.5 -60 -90 -95 -60 -37.4 -70
EPS (Diluted)
-49.6 -33.5 -60 -90 -95 -60 -37.4 -70
EBITDA
-26.59M -17.52M -22.28M -23.71M -23.51M -11.73M -5.11M -11.87M
EBIT
-28.46M -19.39M -24.15M -25.58M -25.38M -13.39M -6.38M -12.95M
Depreciation & Amortization
1.87M 1.87M 1.87M 1.87M 1.87M 1.66M 1.27M 1.08M